Skip to content
Disclosery

Northpond Ventures, LLC

Follow

13F filer, CIK 1911245, Bethesda, MD

Northpond Ventures, LLC reported $60,249,879 across 4 holdings for the quarter ended 2023-06-30, in a 13F-HR filed 2023-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-23-091394

Period
2023-06-30
Reported value
$60.2M
Holdings
4
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DICE THERAPEUTICS INCexited-3,292,871-$94.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2023

Share positions as resolved from 13F-HR 0001104659-23-091394, largest first. % of portfolio is the value over $60,249,879, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
VIGIL NEUROSCIENCE INCVIGIL NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 4,214,498 shares; 2023Q1: 4,214,498 shares; 2023Q2: 4,214,498 shares 4,214,498$39.6M65.75%0
CODEX DNA INCCODEX DNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 9,844,130 shares; 2023Q1: 9,844,130 shares; 2023Q2: 9,844,130 shares 9,844,130$15.6M25.82%0
BERKELEY LTS INCBERKELEY LTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: 5,390,820 shares; 2023Q2: 5,390,820 shares 5,390,820$2.64M4.38%0
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2021Q3: restricted; 2021Q4: restricted; 2022Q1: restricted; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 1,935,215 shares; 2023Q1: 1,935,215 shares; 2023Q2: 1,935,215 shares 1,935,215$2.44M4.05%0Timeline

Sold out in Q2 2023

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
DICE THERAPEUTICS INCDICE THERAPEUTICS INC3,292,871$94.3Mshares

How Q2 2023 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-23-091394 base2023-08-14acceptance time not in the bulk data set